Home Therapeutics Cellular Therapeutics

Cellular Therapeutics

Latest
According to Lotta Ljungqvist
Cellular Therapeutics

GE Healthcare, Swedish Government Open an Innovation Center in Uppsala

Astellas Pharma sees potential in Quethera's gene therapy program
Cellular Therapeutics

Astellas Expands Its Eye Disorder Pipeline with Quethera Purchase

Torque
Cellular Therapeutics

Torque Unveils Manufacturing Platform for Its “Deep Primed” T-Cell Cancer Therapies

Sangamo Therapeutics aims to position itself as a leader in the development of chimeric antigen receptor-modified regulatory T-cell (CAR-Treg) cell therapies for immunological diseases with its planned acquisition of TxCell. [Source: TxCell]
Cellular Therapeutics

Sangamo Looks to Expand into CAR-Treg Cell Therapies with TxCell Acquisition

Source: Cbenner12/Wikipedia
Cellular Therapeutics

Teratoma-Derived Stem Cells Rebuild Muscle in Model of Muscular Dystrophy

(Left two panels) Hepatocyte-like cells (HLCs) differentiated from the stem cells of patients with hemophilia B show very low levels of clotting factor IX
Cellular Therapeutics

CRISPR “One Shot” Cell Therapy for Hemophilia Developed

Cellular Therapeutics

Lonza Opens Cell and Gene Therapy Facility in Pearland, TX

Cellular Therapeutics

Lilly, Sigilon Launch Up-to-$473M+ Type 1 Diabetes Partnership

Cellular Therapeutics

Immunotherapy Raises the Stakes and Ovarian Cancer Blinks

Cellular Therapeutics

MD Anderson, Berkeley Lights Launch Cancer Cell Therapy Company

Load more

Recently Featured

Stay Connected

557,108FansLike
46,506FollowersFollow
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up